Measures of life quality, role performance, and functional status in asthma research

J. M. Richards, M. P. Hemstreet, Laurie J. Bauman

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Recently a consensus has emerged that health care research should address outcomes important to patients, especially quality of life, role performance, and functional status. The assessment of such outcomes is beset by conceptual and methodological difficulties that may be especially problematic for asthma. Nevertheless, several broad conclusions may be drawn about the use of measures of these outcomes in asthma research. Asthma usually is reasonably well controlled if patients are moderately adherent to their recommended regimens. Consequently, the beneficial impacts of interventions are likely to be small, and large samples are required to detect them. Outcome assessment should combine asthma-specific measures with generic measures applicable to a variety of conditions. Generic measures aimed at severely debilitating disease are less appropriate than measures designed for use in the general population. Asthma-specific measures should emphasize the incidence and impact of such symptoms as coughing, wheezing, sputum production, and shortness of breath. Current procedures for computing utility scores and cost-benefit ratios based on them have serious measurement limitations, and use of such scores should be postponed until those limitations are overcome. These assessment issues should be addressed separately for adults and children.

Original languageEnglish (US)
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume149
Issue number2 II
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Asthma
Quality of Life
Research
Outcome Assessment (Health Care)
Health Services Research
Respiratory Sounds
Sputum
Dyspnea
Cost-Benefit Analysis
Incidence
Population

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Measures of life quality, role performance, and functional status in asthma research. / Richards, J. M.; Hemstreet, M. P.; Bauman, Laurie J.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 149, No. 2 II, 01.01.1994.

Research output: Contribution to journalArticle

@article{a828445fd0ed4cdf855534767f9e47fe,
title = "Measures of life quality, role performance, and functional status in asthma research",
abstract = "Recently a consensus has emerged that health care research should address outcomes important to patients, especially quality of life, role performance, and functional status. The assessment of such outcomes is beset by conceptual and methodological difficulties that may be especially problematic for asthma. Nevertheless, several broad conclusions may be drawn about the use of measures of these outcomes in asthma research. Asthma usually is reasonably well controlled if patients are moderately adherent to their recommended regimens. Consequently, the beneficial impacts of interventions are likely to be small, and large samples are required to detect them. Outcome assessment should combine asthma-specific measures with generic measures applicable to a variety of conditions. Generic measures aimed at severely debilitating disease are less appropriate than measures designed for use in the general population. Asthma-specific measures should emphasize the incidence and impact of such symptoms as coughing, wheezing, sputum production, and shortness of breath. Current procedures for computing utility scores and cost-benefit ratios based on them have serious measurement limitations, and use of such scores should be postponed until those limitations are overcome. These assessment issues should be addressed separately for adults and children.",
author = "Richards, {J. M.} and Hemstreet, {M. P.} and Bauman, {Laurie J.}",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "149",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2 II",

}

TY - JOUR

T1 - Measures of life quality, role performance, and functional status in asthma research

AU - Richards, J. M.

AU - Hemstreet, M. P.

AU - Bauman, Laurie J.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Recently a consensus has emerged that health care research should address outcomes important to patients, especially quality of life, role performance, and functional status. The assessment of such outcomes is beset by conceptual and methodological difficulties that may be especially problematic for asthma. Nevertheless, several broad conclusions may be drawn about the use of measures of these outcomes in asthma research. Asthma usually is reasonably well controlled if patients are moderately adherent to their recommended regimens. Consequently, the beneficial impacts of interventions are likely to be small, and large samples are required to detect them. Outcome assessment should combine asthma-specific measures with generic measures applicable to a variety of conditions. Generic measures aimed at severely debilitating disease are less appropriate than measures designed for use in the general population. Asthma-specific measures should emphasize the incidence and impact of such symptoms as coughing, wheezing, sputum production, and shortness of breath. Current procedures for computing utility scores and cost-benefit ratios based on them have serious measurement limitations, and use of such scores should be postponed until those limitations are overcome. These assessment issues should be addressed separately for adults and children.

AB - Recently a consensus has emerged that health care research should address outcomes important to patients, especially quality of life, role performance, and functional status. The assessment of such outcomes is beset by conceptual and methodological difficulties that may be especially problematic for asthma. Nevertheless, several broad conclusions may be drawn about the use of measures of these outcomes in asthma research. Asthma usually is reasonably well controlled if patients are moderately adherent to their recommended regimens. Consequently, the beneficial impacts of interventions are likely to be small, and large samples are required to detect them. Outcome assessment should combine asthma-specific measures with generic measures applicable to a variety of conditions. Generic measures aimed at severely debilitating disease are less appropriate than measures designed for use in the general population. Asthma-specific measures should emphasize the incidence and impact of such symptoms as coughing, wheezing, sputum production, and shortness of breath. Current procedures for computing utility scores and cost-benefit ratios based on them have serious measurement limitations, and use of such scores should be postponed until those limitations are overcome. These assessment issues should be addressed separately for adults and children.

UR - http://www.scopus.com/inward/record.url?scp=0027979519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027979519&partnerID=8YFLogxK

M3 - Article

C2 - 8298767

AN - SCOPUS:0027979519

VL - 149

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2 II

ER -